BOIN12‐PFS: A Bayesian Optimal Interval Phase I/II Design Incorporating Progression‐Free Survival Endpoint

Yusuke Tanaka, Kentaro Takeda, Ryo Kitabayashi, Hiroyuki Sato, Akihiro Hirakawa
Pharmaceutical Statistics · Wiley · 2026-10-05 · DOI: 10.1002/pst.70133

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles